Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Myelodysplastic Syndromes 40Multiple Myeloma 34Lymphoma 32Leukemia 28Lymphoma, Non-Hodgkin 27Leukemia, Lymphocytic, Chronic, B-Cell 24Hodgkin Disease 21Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Hematologic Neoplasms 17Lymphoma, Large B-Cell, Diffuse 16Primary Myelofibrosis 11Neoplasms, Plasma Cell 10Leukemia, Myelomonocytic, Chronic 10Lymphoma, Follicular 9Graft vs Host Disease 9Myeloproliferative Disorders 8Neuroblastoma 7Leukemia, Myelomonocytic, Juvenile 7Lymphoma, Mantle-Cell 6Breast Neoplasms 6Recurrence 5Neoplasms 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Biphenotypic, Acute 5Wilms Tumor 4Rhabdoid Tumor 4Polycythemia Vera 4Lymphoma, T-Cell 4

Interventions

Melphalan 2Alemtuzumab 2fludarabine 1Stem Cell Transplantation 1Sertraline 1Sampling Studies 1Metformin 1Clofarabine 1Bone Marrow Transplantation 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Preleukemia × Stem Cell Transplantation × Clear all
NCT00943592 2014-02-27

Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies

University of Chicago

Phase 1/2 Completed
82 enrolled 12 charts
Other hematologic neoplasm

Leukemia, Preleukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡